甲状腺乳头状癌热消融治疗专家共识(2024版)

Expert consensus on thermal ablation of papillary thyroid cancer (2024 edition)

超声引导下甲状腺乳头状癌热消融治疗已经在临床推广。热消融技术具有微创、安全、有效等优势,但是目前的指南或共识仅局限于低危甲状腺微小乳头状癌。随着临床广泛应用和科研数据的积累,越来越多的证据表明热消融可以治疗较大肿瘤,服务更多甲状腺乳头状癌患者。为了拓展甲状腺乳头状癌热消融治疗的适应证、规范技术细节和围手术期患者管理方案,由中国抗癌协会肿瘤消融治疗专业委员会、中国临床肿瘤学会(CSCO)肿瘤消融专家委员会、中国医师协会介入医师分会肿瘤消融专业委员会、白求恩精神研究会内分泌和糖尿病学分会介入内分泌专业委员会组织国内相关专家,结合目前甲状腺乳头状癌热消融治疗的最新研究进展,讨论制订了本甲状腺乳头状癌热消融治疗专家共识,以推动超声引导下甲状腺乳头状癌热消融治疗在临床的快速发展。

Ultrasound-guided thermal ablation of papillary thyroid cancer(PTC)has been promoted in clinical practice over the past few years.Thermal ablation has the advantages of being minimally invasive,effective,and safe.However,current guidelines and consensus only focus on low-risk papillary thyroid microcarcinoma.With growing clinical application and accumulating scientific research in thermal ablation for PTC,there is considerable evidence to demonstrate that thermal ablation can treat larger PTC tumors and benefit more patients with PTC.To expand the indications and standardize the technical details and perioperative patient management for PTC ablation,experts from the Society of Tumor Ablation Therapy of the Chinese Anti-Cancer Association,the Ablation Expert Committee of the Chinese Society of Clinical Oncology(CSCO),Chinese Medical Doctor Association College of Interventionalists Tumor Ablation Committee,and Chinese Bethune Spirit Research Association Endocrinology and Diabetes Branch Interventional Endocrine Committee discussed and developed a consensus on thermal ablation of PTC based on the latest research results.This consensus aims to promote the rapid development of thermal ablation for PTC in the clinic.